(ABUS) Arbutus Biopharma complete technical analysis [charts+indicators] | Buy/Sell Arbutus Biopharma | (ABUS) share price targets
Complete technical analysis of Arbutus Biopharma (ABUS) by charts plus indicators, forecast predictions and share price targets for Arbutus Biopharma (ABUS)
Arbutus Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2025-06-04 View latest technical analysis
10 day averaged volume of Arbutus Biopharma is 754530
| Date | Daily Closing Price | Open | High | Low | Volume |
| 04 Wed Jun 2025 | 3.41 | 3.46 | 3.48 | 3.36 | 0.703 times |
| 03 Tue Jun 2025 | 3.45 | 3.36 | 3.48 | 3.31 | 0.607 times |
| 02 Mon Jun 2025 | 3.36 | 3.37 | 3.43 | 3.33 | 0.731 times |
| 30 Fri May 2025 | 3.36 | 3.42 | 3.43 | 3.33 | 0.843 times |
| 29 Thu May 2025 | 3.44 | 3.42 | 3.53 | 3.38 | 1.168 times |
| 28 Wed May 2025 | 3.41 | 3.45 | 3.54 | 3.40 | 0.965 times |
| 27 Tue May 2025 | 3.45 | 3.24 | 3.46 | 3.24 | 1.484 times |
| 23 Fri May 2025 | 3.22 | 3.16 | 3.24 | 3.14 | 0.706 times |
| 22 Thu May 2025 | 3.22 | 3.15 | 3.24 | 3.11 | 1.033 times |
| 21 Wed May 2025 | 3.17 | 3.17 | 3.25 | 3.11 | 1.461 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 3.4, but if it comes below 3.4, then a intra day sell could be more profitable.
If you take a sell trade below 3.4, then use 3.4 as stoploss and 3.28 as target. However if you take a buy trade in stock , then use 3.4 as stoploss and 3.5 as target.
Share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Target | 2.70 |
| Downside Target | 2.94 |
| Downside Target | 3.02 |
| Downside Target | 3.11 |
| Downside Target | 3.24 |
| Upside Target | 3.42 |
| Upside Target | 3.48 |
| Upside Target | 3.54 |
| Upside Target | 3.57 |
| Upside Target | 3.62 |
| Upside Target | 3.66 |
| Upside Target | 3.70 |
| Upside Target | 3.73 |
Intraday share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Intraday Target | 3.32 |
| Downside Intraday Target | 3.23 |
| Upside Intraday Target | 3.49 |
| Upside Intraday Target | 3.57 |
| Downside Intraday Target | 3.4 |
Weekly technical analysis of Arbutus Biopharma (ABUS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 04 Wed Jun 2025 | 3.41 | 3.37 | 3.48 | 3.31 | 0.458 times |
| 30 Fri May 2025 | 3.36 | 3.24 | 3.54 | 3.24 | 0.89 times |
| 23 Fri May 2025 | 3.22 | 3.06 | 3.25 | 3.04 | 0.882 times |
| 16 Fri May 2025 | 3.08 | 3.30 | 3.42 | 2.94 | 0.937 times |
| 09 Fri May 2025 | 3.23 | 3.60 | 3.66 | 3.11 | 0.997 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Arbutus Biopharma (ABUS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 04 Wed Jun 2025 | 3.41 | 3.37 | 3.48 | 3.31 | 0.086 times |
| 30 Fri May 2025 | 3.36 | 3.56 | 3.73 | 2.94 | 0.745 times |
| 30 Wed Apr 2025 | 3.55 | 3.46 | 3.62 | 2.70 | 1.305 times |
| 31 Mon Mar 2025 | 3.49 | 3.43 | 3.57 | 3.02 | 1.056 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arbutus Biopharma (ABUS)
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Arbutus Biopharma in short term and the buy signal is strong.
Arbutus Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Arbutus Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.34 and Arbutus Biopharma (ABUS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Arbutus Biopharma in short term and the buy signal is strong.
Arbutus Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Arbutus Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.34 and Arbutus Biopharma (ABUS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.